## EQT: EQT Corporation - XLE: Energy

### Executive Summary

No thesis match: MRS_10 -4.2% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.1% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($51.57)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. EQT (NYSE:EQT) Stock Price Expected to Rise, Mizuho Analyst Says**
- Source: MarketBeat | 20251213T142056 | Bullish | Relevance: 100%
- Mizuho has increased its price target for EQT (NYSE:EQT) to $68 from $60, maintaining an "outperform" rating and suggesting a 21.1% upside. This comes amidst a general "Moderate Buy" consensus from analysts, with an average price target of $64.78. EQT recently surpassed its Q3 EPS estimates, and its revenue saw a 52.6% year-over-year increase.

**2. UBS Raises Price Target for EQT to $76 While Maintaining 'Buy' Rating | EQT Stock News**
- Source: GuruFocus | 20251212T222156 | Bullish | Relevance: 100%
- UBS analyst Josh Silverstein has increased the price target for EQT (EQT) to $76 from $67, while reiterating a "Buy" rating for the stock. This adjustment reflects a 13.43% rise in the price target and continued confidence in EQT's market performance. The revised target is higher than the average Wall Street analyst target of $64.39, but the GuruFocus GF Value suggests a potential downside from the current price.

**3. New Analyst Forecast: $EQT Given $68 Price Target**
- Source: Quiver Quantitative | 20251212T142309 | Somewhat-Bullish | Relevance: 100%
- Nitin Kumar from Mizuho has set a new price target of $68.0 for EQT, aligning with the median target of $66.0 from 13 analysts over the last six months. The article also details recent insider trading activity, with four insider sales and no purchases, as well as significant shifts in institutional holdings for EQT. Additionally, it highlights EQT's recent Q3 2025 revenue of $1.8B, marking a 49.78% increase from the prior year.

**4. EQT Completes Full Exit from Kodiak Gas Services Investment**
- Source: GuruFocus | 20251211T140410 | Somewhat-Bullish | Relevance: 100%
- EQT Corp has fully divested its interests in Kodiak Gas Services, marking its first IPO from the infrastructure portfolio after a seven-year collaboration. The natural gas production company, focusing on Marcellus and Utica shales, maintains a strong financial position despite recent insider selling. EQT's valuation metrics are near one-year lows, and analyst sentiment remains positive, with institutional ownership reflecting strong confidence.

**5. Mizuho Raises EQT Price Target to $68, Maintains Outperform Rati**
- Source: GuruFocus | 20251212T143309 | Bullish | Relevance: 100%
- Mizuho has increased its price target for EQT to $68 from $60, maintaining an Outperform rating, reflecting continued confidence in the company's performance. This adjustment follows various rating actions by other analysts, highlighting ongoing evaluation within the investment community for EQT. EQT, a natural gas production company focused on the Marcellus and Utica shales, aims its operations at marketers, utilities, and industrial operators in the Appalachian Basin.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | UBS | $76 | $67 | +13% |
| 2025-12-12 | Mizuho | $68 | $60 | +13% |
| 2025-11-21 | Scotiabank | $67 | $70 | -4% |
| 2025-11-18 | Piper Sandler | $50 | $49 | +2% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | UBS | main | Buy |
| 2025-12-12 | Mizuho | main | Outperform |
| 2025-11-21 | Scotiabank | main | Sector Perform |
| 2025-11-18 | Piper Sandler | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.06M) |
| Sells | 2 ($3.56M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.7% (+6.2%)
- Blackrock Inc.: 7.7% (+1.1%)
- Wellington Managemen: 6.8% (-1.4%)
- State Street Corpora: 5.4% (+3.4%)
- Morgan Stanley: 3.8% (+12.3%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-2.1% 5d) with bearish MACD, trend may be turning.
2. Insider selling cluster: $3.6M in recent transactions.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 3 raises (avg +10%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 0.49 indicates undervaluation relative to growth. Forward P/E 12.6x attractive for 53% earnings growth. Quality metrics strong (margin 23%). Analyst sentiment positive (3 raises, avg +10%). Insider selling cluster ($3.6M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $34.7B |
| Beta | 0.62 |
| 52W Range | $42.27 - $62.23 |
| Short Interest | 3.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.49 |
| Forward P/E | 12.6 |
| Current P/E | 19.2 |
| YoY Growth | 52.9% |
| EPS Direction | FALLING |

### Technicals

MRS_10 deteriorating from -2.1% to -4.2% (-2.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 7.2pp (needs >3.0% for momentum thesis). Underperforming sector by 4.2pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.03x) but short-term weakness (below SMA20). MACD histogram bearish (-0.58), momentum weakening. RSI neutral at 42. OFD pattern: -MLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -4.19% (CS: 5) | Weak |
| RSI_14 | 41.8 | Neutral |
| MACD Histogram | -0.58 | Bearish |
| vs SMA20 | 0.949x | Below |
| vs SMA50 | 0.980x | Below |
| vs SMA200 | 1.030x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $55.57
- **Stop Loss:** $51.57 (7.2% risk)
- **Target:** $59.57 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 250
- **Position Value:** $13,892.50
- **Portfolio %:** 13.89%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-02-17 (Est: $0.75)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.36 | $0.52 | +42.8% |
| 2025Q2 | $0.41 | $0.45 | +10.0% |
| 2025Q1 | $1.01 | $1.18 | +16.6% |
| 2024Q4 | $0.53 | $0.69 | +31.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*